Why the study?
Is adiponectin associated with newly diagnosed type 2 diabetes in populations with clustering of obesity, dyslipidaemia, and hypertension?
Is adiponectin associated with newly diagnosed type 2 diabetes in populations with clustering of obesity, dyslipidaemia, and hypertension?
The inverse relationship between adiponectin and diabetes risk is attenuated in patients with multiple metabolic risk factors.
Answers are grounded in this paper and cite their sources.
May not aid diabetes risk stratification amid clustered metabolic factors; leaves open adiponectin's incremental value in low-risk groups.
Adiponectin was negatively associated with diabetes and pre-diabetes in a population with few T2DM risk factors, while their relationship gradually attenuated with the accumulation of T2DM risk factors, especially in a population with coexisting diseases such as obesity, hypertension and dyslipidaemia.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: